Cytokinetics Announces First Patient Enrolled In VIGOR-ALS, An Open-Label Extension C
Cytokinetics Announces First Patient Enrolled In VIGOR-ALS, An Open-Label Extension Clinical Trial Of Tirasemtiv
Cytokinetics Announces First Patient Enrolled In VIGOR-ALS An Open-Label Extension Clinical Trial Of Tirasemtiv |
First Patient Enrolled in Extension Trial for Tirasemtiv to Treat ALS
First Patient Enrolled in Extension Trial for Tirasemtiv to Treat ALS
1st Patient Enrolled in ALS Extension Trial Evaluating Tirasemtiv |
All times are GMT -5. The time now is 02:50 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.